Cyclodextrins: promising scaffolds for MRI contrast agents-Reference-Cited by-同舟云学术

Cyclodextrins: promising scaffolds for MRI contrast agents

Published:2021 Issue:47 Volume:11 Page:29762-29785
ISSN:2046-2069
Container-title:RSC Advances
language:en
Short-container-title:RSC Adv.

Author:

Sembo-Backonly Berthe Sandra¹^ORCID,Estour François¹^ORCID,Gouhier Géraldine¹^ORCID

Affiliation:

1. Normandie Université, COBRA UMR 6014, FR 3038, INSA Rouen, CNRS, IRCOF, 1 Rue Tesnière, 76821 Mont-Saint-Aignan, France

Abstract

This review highlights that supramolecular associations using host–guest inclusion complexation and covalent linkages can improve the image contrast, the sensitivity, and the efficiency of MRI diagnosis.

Funder

Université de Rouen

Centre National de la Recherche Scientifique

Région Normandie

Institut National des Sciences Appliquées Rouen

European Regional Development Fund

Publisher

Royal Society of Chemistry (RSC)

Subject

General Chemical Engineering,General Chemistry

Link

http://pubs.rsc.org/en/content/articlepdf/2021/RA/D1RA04084G

Reference105 articles.

1. The issues and tentative solutions for contrast-enhanced magnetic resonance imaging at ultra-high field strength

2. Gadolinium – a specific trigger for the development of nephrogenic fibrosing dermopathy and nephrogenic systemic fibrosis?

3. Possible involvement of gadolinium chelates in the pathophysiology of nephrogenic systemic fibrosis: A critical review

4. Biodistribution of gadolinium-based contrast agents, including gadolinium deposition

5. Efficiency, thermodynamic and kinetic stability of marketed gadolinium chelates and their possible clinical consequences: a critical review

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Gadolinium(III) complex formation with a β-cyclodextrin ligand: an XAS study of a potential MRI contrast agent;JBIC Journal of Biological Inorganic Chemistry;2023-11-20

2. Synthetic Receptors for Early Detection and Treatment of Cancer;Biosensors;2023-10-25

3. Exploring the Potential of Nanogels: From Drug Carriers to Radiopharmaceutical Agents;Advanced Healthcare Materials;2023-09-28

4. Advances in MRI: Peptide and peptidomimetic‐based contrast agents;Journal of Peptide Science;2023-09-19

5. Insights into recent preclinical studies on labelled cyclodextrin-based imaging probes: Towards a novel oncological era;International Journal of Pharmaceutics;2023-06